Gilead Sciences and the Global Fund to Fight AIDS, Tuberculosis and Malaria said on Wednesday they had finalized plans to ...

Lenacapavir, the first FDA-approved, twice-yearly injectable PrEP for HIV prevention, shows 96% efficacy and offers ...

BANGOR -- Lubec’s Regional Healthcare Center has discontinued all it’s HIV service programs. For years, the Regional Medical Center at Lubec has provided outreach counseling, testing, and referrals ...

The risk for MACEs was higher among patients with HIV infection receiving abacavir- vs tenofovir-based ART regimens.

Widespread use of contemporary antiretroviral therapy globally has transformed HIV disease into a chronic illness associated with excess risk for disorders of the heart and circulatory system. Current ...

From the first reported case of AIDS to the present, what is the history of HIV-AIDS and are there parallels to the COVID-19 ...

With approximately 37 million people living with HIV worldwide and an estimated 2 million new infections reported each year, the need to derive novel strategies aimed at eradicating HIV-1 infection ...

Increased PrEP usage is linked to decreased HIV diagnosis rates, with a notable decline from 13.0 to 10.6 per 100,000 over a decade. State-level PrEP coverage significantly impacts HIV diagnosis rates ...

While no-one was diagnosed with either immunodeficiency disease in May or June of 2025 - naturally, the lowest on record since 2024 began - the most HIV/AIDS diagnoses given in a single month was 15.

Elton John: We've made great progress on HIV/AIDS. Budget cuts threaten to set us back. Programs that provide treatment, fuel prevention and fight the stigma of HIV/AIDS should be expanded, not ...

This drug offers 99.9% protection against HIV, but there’s a catch Malathy Iyer TNN Jun 22, 2025, 15:53 IST IST ...

It is interesting to note that a recent study conducted in rural South Africa among 5059 participants aged ≥40 years has shown that HIV‐positive subjects had a lower prevalence of classical CVD risk ...